Introduction to Foster Pharma

Recent advances in drug discovery have led to a new class of promising active pharmaceutical ingredients (APIs) that are poorly water soluble (PWS). These PWS drugs cannot be processed using traditional, aqueous methods. Melt extrusion is emerging as the best technology to solve the problem.

Foster Pharma is a business uniquely positioned to meet this unmet need by virtue of its core capabilities. It can help the customer with the full range of challenges, from developing and compounding raw materials through production using melt extrusion and packaging with:

• Proven technical core competency to develop extrusion processes that incorporate PWS drugs and to develop and mass produce components and devices
• Dedicated facilities required to manufacture compounds, components, and devices to cGMP and ISO standards
• A leadership team with over 50 years combined experience in all phases of compounding, extrusion, and post-processing

	Foster Pharma has the capability to source, compound, extrude, and process many combinations of APIs, excipients, and polymer final products.